Revvity, Inc. (NYSE: RVTY) today announced a program for expansion of its type 1 diabetes (T1D) offering to include a ...

Syntara has reported "outstanding" results for its ongoing myelofibrosis trial, raising hopes for sufferers of the rare blood ...

C2N Diagnostics, a world leader in advanced brain health diagnostics, has reached an exceptional new milestone with the submission of its innovative, accessible blood test to the U.S. Food and Drug ...

CrowdStrike and Kinsale Capital Group have both returned an average of over 40% annually over their publicly traded histories ...

It serves as a point of reference for both investors and analysts. However, not every stock in this select group of ...

ZEITBIKE USA, a bicycle & parts distributor with more than a decade of experience in the U.S. cycling market, is proud to announce the addition of LOOP, an innovative UK-based brand, to its exclusive ...

Affiliated Foods Inc. is investing in forward-thinking technology to enhance the experience for consumers and improve ...

The ASX is looking mighty unsure of which direction to jump, seesawing as resource gains struggle to outweigh losses in ...

Two sizable deals are currently scheduled to price in the week ahead as the 3Q IPO market comes to a close. Read more here.

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract ...

InTEST's performance is heavily influenced by cyclical CapEx trends. See here for INTT stock's role in semiconductor and EV ...

The ASX 200 is looking chipper so far today, taking Wall Street’s tech-happy cues and lifting about 0.35% by about 1pm AEST.